DRUG Royalty III LP

-

Fund Information and Directors

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
DRUG Royalty III LP
Firm DRI Capital Inc
Fund #805-5026152539
CIK #0001565607
Sale2012-12-21 (457.2 M Sold)
FundOther Private Fund
Phone4168631865
Addressc/o Corporation Service Company
Wilmington, Delaware 19808
Source [EDGAR] [IAPD]
Fund AUM and Sold ($M)
110088066044022002009201320172022
Fund Details
DirectorDRUG Royalty III GP LLC
CustodianWells Fargo Bank NA
AuditorDeloitte LLP Canada, Deloitte LLP
MarketerAtlantic - Pacific Capital Inc
Broker
Jurisdiction
Form D Offering
Filed2013-09-16 (D/A)
Exemption506, 3(c), 3(c)(7)
Minimum$100,000
RemainingIndefinite
DurationOne year or less
Commission$4,283,750
RevenueDecline to Disclose
Investors44
DirectorsRole2011 - 2026
Behzad Khosrowshahi Director
Abali Hoilett Director
Ali Hedayat Director
Ali Seirafi Director
William Shaw Director
M Shepherd Director
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com